EUVIMEDEUVIMED entdecken
Crossref

Atomic iron-engineered dual-modal nanozyme enhances tumor-targeted chemodynamic/photothermal synergistic therapy

Cai-Shi Lin, Wenhao Shi, Yanfei Zhu, Weiheng Ma, Yongjian Ai, Jing Wang, Qionglin Liang, Meng-Qi He

Nano Research · 2026-05 · 19 (5) · 94908256

DOI: 10.26599/nr.2025.94908256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Research, 2026-05. Verfasst von Cai-Shi Lin und 7 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To address monotherapy limitations in oncology, synergistic strategies are urgently needed to circumvent drug resistance and achieve favorable therapeutic outcomes. The development of new nanoformulations has emerged as one of the most promising approaches to resolve these challenges. In this study, we engineered an iRGD peptide-functionalized Fe single-atom nanozyme (FeSAN@iRGD) that integrates dual therapeutic modalities. The FeSAN@iRGD demonstrates exceptional peroxidase-like catalytic activity and achieves a remarkable 29.5% photothermal conversion efficiency under 808 nm laser irradiation, enabling effective synergistic chemodynamic therapy (CDT) and photothermal therapy (PTT). Density functional theory calculations reveal that the atomically dispersed Fe-N4 active sites facilitate efficient catalytic conversion of endogenous H2O2 into highly cytotoxic hydroxyl radicals in tumor microenvironment. The surface-conjugated iRGD peptide significantly enhances tumor-targeted accumulation. Both in vitro and in vivo evaluations confirm that the combined CDT/PTT approach synergistically enhances tumor cell apoptosis and suppresses tumor growth. Proteomic analysis comprehensively revealed reactive oxygen species (ROS)-mediated pathways including response to ROS, apoptosis, metabolic reprogramming, and cell cycle. This multifunctional nanozyme provides a promising paradigm for overcoming the therapeutic limitations of conventional cancer treatments through rational integration of catalytic nanomedicine and tumor-targeting strategies.

Zitieren

APA

Lin, C., Shi, W., Zhu, Y., Ma, W., Ai, Y., Wang, J., Liang, Q., & He, M. (2026). Atomic iron-engineered dual-modal nanozyme enhances tumor-targeted chemodynamic/photothermal synergistic therapy. Nano Research, 19(5), 94908256. https://doi.org/10.26599/nr.2025.94908256

Vancouver

Lin C, Shi W, Zhu Y, Ma W, Ai Y, Wang J, et al. Atomic iron-engineered dual-modal nanozyme enhances tumor-targeted chemodynamic/photothermal synergistic therapy. Nano Research. 2026;19(5):94908256. doi:10.26599/nr.2025.94908256

BibTeX
@article{Lin2026,
  author = {Lin, Cai-Shi and Shi, Wenhao and Zhu, Yanfei and Ma, Weiheng and Ai, Yongjian and Wang, Jing and Liang, Qionglin and He, Meng-Qi},
  title = {Atomic iron-engineered dual-modal nanozyme enhances tumor-targeted chemodynamic/photothermal synergistic therapy},
  journal = {Nano Research},
  year = {2026},
  volume = {19},
  number = {5},
  pages = {94908256},
  doi = {10.26599/nr.2025.94908256}
}
Kostenlos starten →